| Views | |
|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 229 |
| May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | November 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 9 | 6 | 16 | 25 | 20 | 21 | 12 |
| Views | |
|---|---|
| Alkhawaldeh_Evaluation_23.pdf | 98 |
| Views | |
|---|---|
| United States | 61 |
| Canada | 36 |
| Germany | 7 |
| China | 4 |
| India | 4 |
| Japan | 4 |
| Netherlands | 4 |
| Vietnam | 4 |
| Brazil | 3 |
| Australia | 2 |
| Views | |
|---|---|
| Ottawa | 30 |
| Houston | 17 |
| Mountain View | 6 |
| San Francisco | 6 |
| Durham | 4 |
| Mumbai | 4 |
| Dearborn | 3 |
| Kanda | 3 |
| Washington | 3 |
| Aalsmeer | 2 |